Cargando…
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
Amidst the therapeutic void at the onset of the COVID-19 pandemic, a critical mass of scientific and clinical interest coalesced around COVID-19 convalescent plasma (CCP). To date, the CCP literature has focused largely on safety and efficacy outcomes, but little on implementation outcomes or experi...
Autores principales: | Root, Heather B., Gilleskie, Matt, Lu, Chih-Huan, Gilmore, Andrew, Evans, Mariama, Nelson, Bridget G., Johnson, William, Gurney, Brian, Kuruc, JoAnn, Markmann, Alena J., Barzin, Amir H., Wohl, David A., Fischer, William A., Park, Yara A., Weiss, Susan, Napravnik, Sonia, Baric, Ralph, de Silva, Aravinda M., Lachiewicz, Anne M., van Duin, David, Margolis, David M., Herce, Michael E., Bartelt, Luther A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731422/ https://www.ncbi.nlm.nih.gov/pubmed/36480499 http://dx.doi.org/10.1371/journal.pone.0277707 |
Ejemplares similares
-
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
por: Bartelt, Luther A., et al.
Publicado: (2022) -
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021) -
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021) -
Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
por: Markmann, Alena J., et al.
Publicado: (2021) -
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020)